We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
351
DELISTED
Intersect ENT, Inc
XENT
| $3.36M | 0.06% |
103,722
+58,260
| +128% | +$1.75M |
|
|
IRBT
352
DELISTED
iRobot
IRBT
| $3.34M | 0.06% |
43,520
+14,280
| +49% | +$1.03M |
|
|
SC
353
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $3.33M | 0.06% |
178,700
+114,200
| +177% | +$1.91M |
|
354
Stoneridge
SRI
$209M
| $3.3M | 0.06% |
144,491
+6,401
| +5% | +$143K |
|
355
Take-Two Interactive
TTWO
$43B
| $3.3M | 0.06% |
30,080
+8,960
| +42% | +$978K |
|
356
Rapid7
RPD
$634M
| $3.26M | 0.06% |
174,930
+17,700
| +11% | +$328K |
|
357
Cohu
COHU
$2.39B
| $3.25M | 0.06% |
147,829
+42,431
| +40% | +$1.01M |
|
|
MNTA
358
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.23M | 0.06% |
231,862
+42,943
| +23% | +$580K |
|
|
RPAI
359
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $3.23M | 0.06% |
240,196
+3,700
| +2% | +$48.1K |
|
|
HDP
360
DELISTED
Hortonworks, Inc.
HDP
| $3.23M | 0.06% |
160,496
-9,700
| -6% | -$178K |
|
361
Korn Ferry
KFY
$3.98B
| $3.21M | 0.06% |
+77,600
| New | +$3.22M |
|
362
AngioDynamics
ANGO
$562M
| $3.21M | 0.06% |
193,046
+58,632
| +44% | +$1M |
|
363
Enovis
ENOV
$1.56B
| $3.21M | 0.06% |
47,038
+21,183
| +82% | +$1.43M |
|
364
Kosmos Energy
KOS
$1.56B
| $3.21M | 0.06% |
+467,939
| New | +$3.56M |
|
365
Jack in the Box
JACK
$278M
| $3.2M | 0.06% |
32,580
+960
| +3% | +$97.6K |
|
366
Enova International
ENVA
$5.91B
| $3.15M | 0.06% |
207,511
+26,908
| +15% | +$395K |
|
367
Workiva
WK
$2.94B
| $3.15M | 0.06% |
147,229
+49,219
| +50% | +$1.08M |
|
368
Central Pacific Financial
CPF
$997M
| $3.14M | 0.06% |
105,238
+50,628
| +93% | +$1.58M |
|
369
Associated Banc-Corp
ASB
$5.81B
| $3.12M | 0.05% |
122,984
+57,800
| +89% | +$1.44M |
|
|
MODV
370
DELISTED
ModivCare
MODV
| $3.12M | 0.05% |
52,619
+11,099
| +27% | +$629K |
|
371
Biogen
BIIB
$29.9B
| $3.11M | 0.05% |
9,774
-4,722
| -33% | -$1.51M |
|
372
Kelly Services Class A
KELYA
$526M
| $3.08M | 0.05% |
112,971
+41,711
| +59% | +$1.15M |
|
|
CERN
373
DELISTED
Cerner Corp
CERN
| $3.07M | 0.05% |
45,590
+20,060
| +79% | +$1.39M |
|
374
Kulicke & Soffa
KLIC
$5.3B
| $3.06M | 0.05% |
125,691
-27,520
| -18% | -$656K |
|
375
Seagate
STX
$193B
| $3.05M | 0.05% |
72,891
-2,200
| -3% | -$84K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.